1 Pierson, T. C. & Diamond, M. S. The continued threat of emerging flaviviruses. Nat Microbiol 5, 796-812, doi:10.1038/s41564-020-0714-0 (2020).
2 Suwanmanee, S. & Luplertlop, N. Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses. Journal of Microbiology 55, 81-89, doi:10.1007/s12275-017-6494-4 (2017).
3 Rodriguez-Morales, A. J., Villamil-Gómez, W. E. & Franco-Paredes, C. The arboviral burden of disease caused by co-circulation and co-infection of dengue, chikungunya and Zika in the Americas. Travel medicine and infectious disease 14, 177-179, doi:10.1016/j.tmaid.2016.05.004 (2016).
4 Lessler, J. et al. Assessing the global threat from Zika virus. Science 353, aaf8160, doi:10.1126/science.aaf8160 (2016).
5 Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nature immunology, doi:10.1038/ni.3515 (2016).
6 Priyamvada, L. et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proceedings of the National Academy of Sciences of the United States of America 113, 7852-7857, doi:10.1073/pnas.1607931113 (2016).
7 Allicock, O. M. et al. Determinants of dengue virus dispersal in the Americas. Virus Evol 6, veaa074, doi:10.1093/ve/veaa074 (2020).
8 Zellweger, R. M. et al. CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice. J Virol 89, 6494-6505, doi:10.1128/jvi.00036-15 (2015).
9 Katzelnick, L. C. et al. Dengue viruses cluster antigenically but not as discrete serotypes. Science 349, 1338-1343, doi:10.1126/science.aac5017 (2015).
10 Chen, R. E. et al. Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell host & microbe, doi:10.1016/j.chom.2021.09.006 (2021).
11 Bhatt, P., Sabeena, S. P., Varma, M. & Arunkumar, G. Current Understanding of the Pathogenesis of Dengue Virus Infection. Curr Microbiol, doi:10.1007/s00284-020-02284-w (2020).
12 Guzman, M. G., Alvarez, M. & Halstead, S. B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158, 1445-1459, doi:10.1007/s00705-013-1645-3 (2013).
13 Culshaw, A., Mongkolsapaya, J. & Screaton, G. R. The immunopathology of dengue and Zika virus infections. Curr Opin Immunol 48, 1-6, doi:10.1016/j.coi.2017.07.001 (2017).
14 Rogers, T. F. et al. Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Sci Immunol 2, doi:10.1126/sciimmunol.aan6809 (2017).
15 Bhaumik, S. K. et al. Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient. Viruses 11, doi:10.3390/v11010019 (2018).
16 Grifoni, A. et al. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans. J Virol 91, doi:10.1128/jvi.01469-17 (2017).
17 Lim, M. Q. et al. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus. Front Immunol 9, 2225, doi:10.3389/fimmu.2018.02225 (2018).
18 Katzelnick, L. C., Bos, S. & Harris, E. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus. Curr Opin Virol 43, 59-70, doi:10.1016/j.coviro.2020.08.006 (2020).
19 Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci U S A 110, E2046-2053, doi:10.1073/pnas.1305227110 (2013).
20 Wen, J. et al. Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge. Nat Commun 8, 1459, doi:10.1038/s41467-017-01669-z (2017).
21 Regla-Nava, J. A. et al. Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy. Nat Commun 9, 3042, doi:10.1038/s41467-018-05458-0 (2018).
22 Elong Ngono, A. et al. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection. EBioMedicine 13, 284-293, doi:10.1016/j.ebiom.2016.10.006 (2016).
23 Wen, J. et al. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8(+) T cells. Nat Microbiol 2, 17036, doi:10.1038/nmicrobiol.2017.36 (2017).
24 Weiskopf, D. et al. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci U S A 112, E4256-4263, doi:10.1073/pnas.1505956112 (2015).
25 Hassert, M. et al. CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection. PLoS Pathog 14, e1007237, doi:10.1371/journal.ppat.1007237 (2018).
26 Wen, J. et al. CD4(+) T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection. Cell Rep 31, 107566, doi:10.1016/j.celrep.2020.107566 (2020).
27 Elong Ngono, A. et al. CD4+ T cells promote humoral immunity and viral control during Zika virus infection. PLoS Pathog 15, e1007474, doi:10.1371/journal.ppat.1007474 (2019).
28 Rouers, A. et al. Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection. Cell Rep Med 2, 100278, doi:10.1016/j.xcrm.2021.100278 (2021).
29 Serrano-Collazo, C. et al. Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies. PLoS Negl Trop Dis 14, e0008285, doi:10.1371/journal.pntd.0008285 (2020).
30 St John, A. L. & Rathore, A. P. S. Adaptive immune responses to primary and secondary dengue virus infections. Nat Rev Immunol 19, 218-230, doi:10.1038/s41577-019-0123-x (2019).
31 Saron, W. A. A. et al. Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. Sci Adv 4, eaar4297, doi:10.1126/sciadv.aar4297 (2018).
32 Simon-Lorière, E. et al. Increased adaptive immune responses and proper feedback regulation protect against clinical dengue. Sci Transl Med 9, doi:10.1126/scitranslmed.aal5088 (2017).
33 Weiskopf, D. et al. HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses. J Infect Dis 214, 1117-1124, doi:10.1093/infdis/jiw309 (2016).
34 Wong, R. et al. Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses. Immunity 53, 1078-1094.e1077, doi:10.1016/j.immuni.2020.09.001 (2020).
35 Mathew, A. et al. B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis 204, 1514-1522, doi:10.1093/infdis/jir607 (2011).
36 Saron, W. A. A. et al. <em>Flavivirus</em> serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. Science Advances 4, eaar4297, doi:10.1126/sciadv.aar4297 (2018).
37 Friberg, H. et al. Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans. Scientific reports 1, 51, doi:10.1038/srep00051 (2011).
38 Tsai, W. Y. et al. High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. J Virol 87, 12562-12575, doi:10.1128/jvi.00871-13 (2013).
39 Xu, M. et al. Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. J Immunol 189, 5877-5885, doi:10.4049/jimmunol.1201688 (2012).
40 Priyamvada, L. et al. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts. J Virol 90, 5574-5585, doi:10.1128/jvi.03203-15 (2016).
41 Sariol, C. A. & White, L. J. Utility, limitations, and future of non-human primates for dengue research and vaccine development. Front Immunol 5, 452, doi:10.3389/fimmu.2014.00452 (2014).
42 Sariol, C. A. et al. Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One 6, e19323, doi:10.1371/journal.pone.0019323 (2011).
43 Borges, M. B. et al. Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques. PloS one 13, e0196311-e0196311, doi:10.1371/journal.pone.0196311 (2018).
44 Pantoja, P. et al. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun 8, 15674, doi:10.1038/ncomms15674 (2017).
45 Breitbach, M. E. et al. Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques. PLoS Pathog 15, e1007766, doi:10.1371/journal.ppat.1007766 (2019).
46 McCracken, M. K. et al. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS pathogens 13, e1006487, doi:10.1371/journal.ppat.1006487 (2017).
47 Ana Carolina Bernardes Terzian, A. S. S., Mânlio Tasso de Oliveira Mota, Rafael Alves da Silva, Cássia Fernanda Estofolete, Tatiana Elias Colombo, Paula Rahal, Kathryn A. Hanley, Nikos Vasilakis, Jorge Kalil, Maurício Lacerda Nogueira. Viral load and cytokine response profile does not support antibody-dependent enhancement in dengue-primed Zika-infected patients. Clin Infect Dis DOI 10.1093/cid/cix558, doi:doi.org/10.1093/cid/cix558 (2017).
48 Gordon, A. et al. Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua. PLoS medicine 16, e1002726, doi:10.1371/journal.pmed.1002726 (2019).
49 Grifoni, A. et al. Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans. J Virol DOI 10.1128/jvi.01469-17, doi:10.1128/jvi.01469-17 (2017).
50 Rodriguez-Barraquer, I. et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science (New York, N.Y.) 363, 607-610, doi:10.1126/science.aav6618 (2019).
51 Pérez-Guzmán, E. X. et al. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses. Nat Commun 10, 4316, doi:10.1038/s41467-019-12295-2 (2019).
52 Grifoni, A. et al. Global Assessment of Dengue Virus-Specific CD4(+) T Cell Responses in Dengue-Endemic Areas. Frontiers in immunology 8, 1309-1309, doi:10.3389/fimmu.2017.01309 (2017).
53 Manh, D. H. et al. Kinetics of CD4(+) T Helper and CD8(+) Effector T Cell Responses in Acute Dengue Patients. Frontiers in immunology 11, 1980-1980, doi:10.3389/fimmu.2020.01980 (2020).
54 Duangchinda, T. et al. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proceedings of the National Academy of Sciences of the United States of America 107, 16922-16927, doi:10.1073/pnas.1010867107 (2010).
55 Mongkolsapaya, J. et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9, 921-927, doi:10.1038/nm887 (2003).
56 Rothman, A. L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11, 532-543, doi:10.1038/nri3014 (2011).
57 Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507, doi:10.1038/nature12060 (2013).
58 Patel, B. et al. Dissecting the human serum antibody response to secondary dengue virus infections. PLoS neglected tropical diseases 11, e0005554, doi:10.1371/journal.pntd.0005554 (2017).
59 Wahala, W. M. & Silva, A. M. The human antibody response to dengue virus infection. Viruses 3, 2374-2395, doi:10.3390/v3122374 (2011).
60 Lam, J. H. et al. Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies. JCI Insight 2, doi:10.1172/jci.insight.94500 (2017).
61 Fink, K. et al. B Cell Activation State-Governed Formation of Germinal Centers following Viral Infection. The Journal of Immunology 179, 5877-5885, doi:10.4049/jimmunol.179.9.5877 (2007).
62 Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667-671, doi:10.1038/nature06890 (2008).
63 Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature immunology 10, 116-125, doi:10.1038/ni.1688 (2009).
64 Balakrishnan, T. et al. Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One 6, e29430, doi:10.1371/journal.pone.0029430 (2011).
65 Fink, K. Origin and Function of Circulating Plasmablasts during Acute Viral Infections. Frontiers in immunology 3, 78, doi:10.3389/fimmu.2012.00078 (2012).
66 Yauch, L. E. et al. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. Journal of immunology (Baltimore, Md. : 1950) 185, 5405-5416, doi:10.4049/jimmunol.1001709 (2010).
67 Andrade, P. et al. Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika. Nature communications 10, 938, doi:10.1038/s41467-019-08845-3 (2019).
68 ICTV. Virus Taxonomy, Online Meeting, October. https://talk.ictvonline.org/ictv-reports/ictv_online_report/positive-sense-rna-viruses/w/flaviviridae/360/genus-flavivirus (2020).
69 Calisher, C. H. et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70 ( Pt 1), 37-43, doi:10.1099/0022-1317-70-1-37 (1989).
70 Reynolds, C. J. et al. T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses. Scientific reports 8, 672, doi:10.1038/s41598-017-18781-1 (2018).
71 Rivino, L. & Lim, M. Q. CD4(+) and CD8(+) T-cell immunity to Dengue - lessons for the study of Zika virus. Immunology 150, 146-154, doi:10.1111/imm.12681 (2017).
72 Andrade, P. et al. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue. J Infect Dis 222, 590-600, doi:10.1093/infdis/jiaa120 (2020).
73 Appanna, R. et al. Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool. EBioMedicine 12, 178-188, doi:10.1016/j.ebiom.2016.09.003 (2016).
74 Zompi, S., Montoya, M., Pohl, M. O., Balmaseda, A. & Harris, E. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS neglected tropical diseases 6, e1568, doi:10.1371/journal.pntd.0001568 (2012).
75 Graham, N. et al. Rapid Induction and Maintenance of Virus-Specific CD8(+) T(EMRA) and CD4(+) T(EM) Cells Following Protective Vaccination Against Dengue Virus Challenge in Humans. Frontiers in immunology 11, 479, doi:10.3389/fimmu.2020.00479 (2020).
76 Tian, Y., Grifoni, A., Sette, A. & Weiskopf, D. Human T Cell Response to Dengue Virus Infection. Frontiers in immunology 10, 2125, doi:10.3389/fimmu.2019.02125 (2019).
77 Aberle, J. H., Koblischke, M. & Stiasny, K. CD4 T cell responses to flaviviruses. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 108, 126-131, doi:10.1016/j.jcv.2018.09.020 (2018).
78 Collins, M. & de Silva, A. Host response: Cross-fit T cells battle Zika virus. Nature microbiology 2, 17082, doi:10.1038/nmicrobiol.2017.82 (2017).
79 Kanthaswamy, S. et al. The Population Genetic Composition of Conventional and SPF Colonies of Rhesus Macaques (Macaca mulatta) at the Caribbean Primate Research Center. Journal of the American Association for Laboratory Animal Science : JAALAS 55, 147-151 (2016).
80 Kanthaswamy, S. et al. Population Genetic Structure of the Cayo Santiago Colony of Rhesus Macaques (Macaca mulatta). Journal of the American Association for Laboratory Animal Science : JAALAS 56, 396-401 (2017).
81 Kanthaswamy, S. et al. Determination of major histocompatibility class I and class II genetic composition of the Caribbean Primate Center specific pathogen-free rhesus macaque (Macaca mulatta) colony based on massively parallel sequencing. J Med Primatol 47, 379-387, doi:10.1111/jmp.12353 (2018).
82 Widdig, A. et al. Low incidence of inbreeding in a long-lived primate population isolated for 75 years. Behavioral ecology and sociobiology 71, 18, doi:10.1007/s00265-016-2236-6 (2017).